Dr. Kourous Rezaei Collaborated on a Study Led by the International Retina Biosimilar Study Group 2026
Posted on January 16, 2026 by Illinois Retina Associates in News and Events
Illinois Retina Associates is proud to announce that Dr. Kourous Rezaei collaborated on a multicenter Korean study led by the International Retina Biosimilar Study Group. The study, published January 9, 2026 (Scientific Reports), shows ranibizumab biosimilars (Amelivu & LucenBS) work effectively and safely in real-world retinal disease care — improving vision and eye health with minimal side effects!
Why it matters: This large multicenter study supports that these more affordable biosimilar options can deliver meaningful vision benefits and are well tolerated across diverse retinal diseases in everyday practice.
Check it out here!